Elucidating the pathway for arsenic methylation

Toxicology and Applied Pharmacology

Volumn 198, Issue 3, 2004, Pages 319-326

  Thomas, David J ^a,e   Waters, Stephen B ^b   Styblo, Miroslav ^c,d  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d IL   (United States)

^e Pharmacokinetics Branch   (United States)

Author keywords

Arsenic; Arsenic methyltransferase; cyt19; Methylated arsenicals; Methylation; methyltransferase; Rat; Reductants; Thioredoxin

Indexed keywords

ARSENIC; ARSENIC METHYLTRANSFERASE; ARSENIC TRIOXIDE; METHYLTRANSFERASE; S ADENOSYLMETHIONINE; THIOREDOXIN; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARSENIC POISONING; ARTICLE; CATALYSIS; CONTROLLED STUDY; GENOME; LIVER CYTOSOL; LIVER METABOLISM; METHYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; RNA TRANSLATION;

ANIMALS; ARSENIC; BASE SEQUENCE; CYTOSOL; LIVER; MALE; METHYLATION; METHYLTRANSFERASES; RATS; RATS, INBRED F344; THIOREDOXIN;

EID: 3242785734     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.10.020     Document Type: Article

References (51)

1. Ahmad S., Kitchin K.T., Cullen W.R. Plasmid DNA damage caused by methylated arsenicals, ascorbic acid and human liver ferritin. Toxicol. Lett. 133:2002;47-57
2. Aposhian H.V., Gurzau E.S., Le X.C., Gurzau A., Healy S.M., Lu X., Ma M., Yip L., Zakharyan R.A., Maiorino R.M., Dart R.C., Tircus M.G., Gonzalez-Ramirez D., Morgan D.L., Avram D., Aposhian M.M. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 13:2000;693-697
3. Braman R.S., Foreback C.C. Methylated forms of arsenic in the environment. Science. 182:1973;1247-1249
4. Buchet J.P., Lauwerys R. Study of inorganic arsenic methylation by rat in vitro: relevance for the interpretation of observations in man. Arch. Toxicol. 57:1985;125-129
5. Buchet J.P., Lauwerys R. Role of thiols in the in vitro methylation of inorganic arsenic by rat liver cytosol. Biochem. Pharmacol. 37:1988;3149-3153
6. Buchet J.P., Lauwerys R., Roels H. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite. Int. Arch. Occup. Environ. Health. 48:1981;111-118
7. Challenger F. Biological methylation. Chem. Rev. 36:1945;315-362
8. Challenger F. Biological methylation. Adv. Enzymol. 12:1951;432-491
9. Challenger F., Higginbottom C., Ellis L. The formation of organo-metalloidal compounds by microorganisms: Part I. Trimethylarsine and dimethylarsine. J. Chem. Soc. 1933:1933;95-101
10. Crecelius E.A. Changes in the chemical speciation of arsenic following ingestion by man. Environ. Health Perspect. 19:1977;147-150
11. Cullen W.R., McBride B.C., Reglinski J. The reduction of trimethylarsine oxide to trimethylarsine by thiols: a mechanistic model for the biological reduction of arsenicals. J. Inorg. Biochem. 21:1984;45-60
12. Del Razo L.M., Styblo M., Cullen W.R., Thomas D.J. Determination of trivalent methylated arsenicals in biological matrices. Toxicol. Appl. Pharmacol. 174:2001;282-293
13. Drobna Z., Jaspers I., Thomas D.J., Styblo M. Differential activation of AP-1 in human bladder epithelial cells by inorganic and methylated arsenicals. FASEB J. 17:2003;67-69
14. Gebel T.W. Arsenic methylation is a process of detoxification through accelerated excretion. Int. J. Hyg. Environ. Health. 205:2002;505-508
15. Gregus Z., Nemeti B. Purine nucleoside phosphorylase as a cytosolic arsenate reductase. Toxicol. Sci. 70:2002;13-19
16. Hirata M., Mohri T., Hisanaga A., Ishinishi N. Conversion of arsenite and arsenate to methylarsenic and dimethylarsenic compounds by homogenates prepared from livers and kidneys of rats and mice. Appl. Organomet. Chem. 3:1989;335-341
17. Lakso J.U., Peoples S.A. Methylation of inorganic arsenic by mammals. J. Agric. Food Chem. 23:1975;676
18. Le X.C., Lu X., Ma M., Cullen W.R., Aposhian H.V., Zheng B. Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 72:2000;5172-5177
19. Lin S., Cullen W.R., Thomas D.J. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem. Res. Toxicol. 12:1999;924-930
20. Lin S., Del Razo L.M., Styblo M., Wang C., Cullen W.R., Thomas D.J. Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem. Res. Toxicol. 14:2001;305-311
21. Lin S., Shi Q., Nix F.B., Styblo M., Beck M.A., Herbin-Davis K.M., Hall L.L., Simeonsson J.B., Thomas D.J. A novel S-adenosyl-l-methionine: arsenic(III) methyltransferase from rat liver cytosol. J. Biol. Chem. 277:2002;10795-10803
22. Mass M.J., Tennant A., Roop B.C., Cullen W.R., Styblo M., Thomas D.J., Kligerman A.D. Methylated trivalent arsenic species may be the proximate or ultimate genotoxic forms of arsenic. Chem. Res. Toxicol. 14:2001;355-361
23. Messens J., Martins J.C., Brosens E., Van Belle K., Jacobs D.M., Willem R., Wyns L. Kinetics and active site dynamics of Staphylococcus aureus arsenate reductase. J. Biol. Inorg. Chem. 7:2002;146-156
24. Messens J., Martins J.C., VanBelle K., Brosens E., Desmyter A., DeGieter M., Wieruszeski J.-M., Willem R., Wyns L., Zegers I. All intermediates of the arsenate reductase mechanism, including an intramolecular dynamic disulfide cascade. Proc. Natl. Acad. Sci. U.S.A. 99:2002;8506-8511
25. Mukhopadhyay R., Shi J., Rosen B.P. Purification and characterization of ACR2p, the Saccharomyces cerevisiae arsenate reductase. J. Biol. Chem. 275:2000;21149-21157
26. Nemeti B., Gregus Z. Reduction of arsenate to arsenite in hepatic cytosol. Toxicol. Sci. 70:2002;4-12
27. Nesnow S., Roop B.C., Lambert G., Kadiiska M., Mason R.P., Cullen W.R., Mass M.J. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 15:2002;1627-1634
28. Odanaka Y., Matano O., Goto S. Biomethylation of inorganic arsenic by the rat and some laboratory animals. Bull. Environ. Contam. Toxicol. 24:1980;452-459
29. Peoples S.A. Review of arsenical pesticides. Woolson E.A. Arsenical Pesticides. 1975;1-12 American Chemical Society, Washington
30. Peters R.A. Biochemistry of some toxic agents: I. Present state of knowledge of biochemical lesions induced by trivalent arsenical poisoning. Bull. Johns Hopkins Hosp. 97:1955;1-20
31. Petrick J.S., Ayala-Fierro F., Cullen W.R., Carter D.E., Aposhian H.V. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163:2000;203-207
32. Petrick J.S., Jagadish B., Mash E.A., Aposhian H.V. Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamster and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14:2001;651-656
33. Radabaugh T.R., Sampayo-Reyes A., Zakharyan R.A., Aposhian H.V. Arsenate reductase: II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chem. Res. Toxicol. 15:2002;692-698
34. Sampayo-Reyes A., Zakharyan R.A., Healy S.M., Aposhian H.V. Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue. Chem. Res. Toxicol. 13:2000;1181-1186
35. Smith T.J., Crecelius E.A., Reading J.C. Airborne arsenic exposure and excretion of methylated arsenic compounds. Environ. Health Perspect. 19:1977;89-93
36. Styblo M., Delnomdedieu M., Hughes M.F., Thomas D.J. Identification of methylated metabolites of inorganic arsenic by thin-layer chromatography. J. Chromatogr. B: Biomed. Sci. Appl. 668:1995;21-29
37. Styblo M., Serves S.V., Cullen W.R., Thomas D.J. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 10:1997;27-33
38. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in human cells. Arch. Toxicol. 74:2000;289-299
39. Styblo M., Drobna Z., Jaspers I., Lin S., Thomas D.J. The role of biomethylation in toxicity and carcinogenicity of arsenic. A research update. Environ. Health Perspect. 110(Suppl. 5):2002;767-771
40. Takahashi K., Yamauchi H., Mashiko M., Yamamura Y. The effect of S-adenosylmethionine on methylation of inorganic arsenic. Nippon Eiseigaku Zasshi. 45:1990;613-618
41. Tam G.K.H., Charbonneau S.M., Lacroix G., Bryce F. Confirmation of inorganic arsenic and dimethylarsenic in urine and plasma of dog by ion-exchange and TLC. Bull. Environ. Contam. Toxicol. 21:1979;371-374
42. 74As in urine, plasma and red blood cells of human and dog. Bull. Environ. Contam. Toxicol. 22:1979;69-71
43. Vahter M. Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 82:1999;69-88
44. Vahter M. Mechanisms of arsenic biotransformation. Toxicology. 181-182:2002;211-217
45. Yamamura Y., Yamauchi H. Arsenic metabolites in hair, blood and urine in workers exposed to arsenic trioxide. Ind. Health. 18:1980;203-210
46. Yamanaka K., Hayashi H., Tachikawa M., Kato K., Hasegawa A., Oku N., Okada S. Metabolic methylation is a possible genotoxicity-enhancing process of inorganic arsenics. Mutat. Res. 394:1997;95-101
47. Yamauchi H., Fowler B.A. Toxicity and metabolism of inorganic and methylated arsenicals. Nriagu J.O. Arsenic in the Environment, Part II: Human Health and Ecosystem Effects. 1994;35-43 Wiley, New York
48. Zakharyan R.A., Aposhian H.V. Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase. Chem. Res. Toxicol. 12:1999;1278-1283
49. Zakharyan R., Wu Y., Bogdan G.M., Aposhian H.V. Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase from rabbit liver. Chem. Res. Toxicol. 8:1995;1029-1038
50. Zakharyan R.A., Ayala-Fierro F., Cullen W.R., Carter D.M., Aposhian H.V. Enzymatic methylation of arsenic compounds: VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 158:1999;9-15
51. Zakharyan R.A., Sampayo-Reyes A., Healy S.M., Tsaprailis G., Board P.G., Liebler D.C., Aposhian H.V. Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem. Res. Toxicol. 14:2001;1051-1057